drugIndia
Cart
Glimfirst-MP 2 Tablet SR

Glimfirst-MP 2 Tablet SR

Metformin (500mg) + Glimepiride (2mg) + Pioglitazone (15mg)

Zyphar's Pharmaceuticals Pvt Ltd
ANTI-INFECTION
75.3394.1620% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 68%
Best Alternative100% Match

Glynet-PM2 Tablet ER

Zeelab Pharmacy Pvt Ltd

Pioglitazone 15mg
Glynet-PM2 Tablet ER

Pack Size

1 units

Price

24.0020% off
Glynet-PM2 Tablet ER is 100% same as Glimfirst-MP 2 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹51

that's 68% off!

composition
  1. Pioglitazone 15mg
  2. Glimepiride 2mg
  3. Metformin 500mg
Buy Now
75.3320% OFF
94.16

About This Medicine

Product description & overview

Glimfirst-MP 2 Tablet SR: A Comprehensive Treatment for Type 2 Diabetes

Glimfirst-MP 2 Tablet SR is a unique combination tablet designed to effectively manage type 2 diabetes. This formulation integrates three powerful medications: Glimepiride (2mg), Metformin (500mg), and Pioglitazone (15mg).

How it works: Each drug acts on different aspects of glucose metabolism:

* Glimepiride: Improves insulin sensitivity by stimulating the pancreas to produce more insulin.
* Metformin: Reduces hepatic glucose production, helping lower blood sugar levels.
* Pioglitazone: Promotes glucose uptake into cells, further contributing to blood sugar control.

This triple-action formula allows for a comprehensive approach in managing type 2 diabetes. Glimfirst-MP 2 Tablet SR is formulated as sustained-release (SR) tablets for optimal release and consistent drug levels throughout the day. This formulation ensures safe and effective treatment without the need for frequent dosing adjustments.

Consult your healthcare professional before starting any new medication. Glimfirst-MP 2 Tablet SR may interact with certain other medications or have side effects; their full details are available in the product's information leaflet.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride2 mg
Pioglitazone15 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Pioglitazone

Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimfirst-MP 2 Tablet SR.

High Risk

Pregnancy

Glimfirst-MP 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimfirst-MP 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimfirst-MP 2 Tablet SR may be needed. Please consult your doctor. Use of Glimfirst-MP 2 Tablet SR is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimfirst-MP 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glimfirst-MP 2 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glimfirst-MP 2 Tablet SR may be needed. Please consult your doctor. Use of Glimfirst-MP 2 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glimfirst-MP 2 Tablet SR

Products matching your search